Stay updated on Ixekizumab Delivery in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab Delivery in Psoriasis Clinical Trial page.

Latest updates to the Ixekizumab Delivery in Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the page metadata. This is an administrative update that does not change study details or how a user interacts with the page.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 across the page.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.4.2 has been added to the page, and the funding-lapse notice along with Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check44 days agoChange DetectedA site-wide funding-status notice was added and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedAdded a 'Show glossary' control and new metadata items (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); removed the previous lowercase/older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check65 days agoChange DetectedRevision: v3.3.4 updated from v3.3.3. This is a minor label change that does not affect content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ixekizumab Delivery in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab Delivery in Psoriasis Clinical Trial page.